- Final report of initial preclinical study confirms Cymerus™ MSCs have significant beneficial effects on all three key components of asthma: airway hyper-responsiveness, inflammation and airway remodelling - Additional preclinical study ...
LONDON , March 1, 2017 /PRNewswire/ -- The Global Respiratory Partnering 2010-2017: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the respiratory partnering deals and agreements ...
NEW YORK , Feb. 27, 2017 /PRNewswire/ -- Pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary route ...
LONDON , Feb. 27, 2017 /PRNewswire/ -- l respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, ...
NEW YORK , Feb. 22, 2017 /PRNewswire/ -- Summary Provides understanding and access to the spinal cord partnering deals and agreements entered into by the worlds leading healthcare companies.Read the full report: ...
CHICAGO , Feb. 22, 2017 /PRNewswire-USNewswire/ -- Patti Tuomey , Ed.D., president and CEO of the Pulmonary Fibrosis Foundation (PFF), will leave the Foundation on March 3, 2017 , to become the president and CEO of Josephinum of the Sacred ...
PUNE, India , February 20, 2017 /PRNewswire/ -- According to a new market research report " Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, ...
HILDEN , Germany and GERMANTOWN, Maryland , February 16, 2017 /PRNewswire/ -- Results Suggest Benefits of Quantitative Screening of Young Children in Countries With High TB Burden QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime ...
NEW YORK , Feb. 14, 2017 /PRNewswire/ -- Summary Provides understanding and access to the tuberculosis partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Tuberculosis Partnering ...
LONDON , Feb. 14, 2017 /PRNewswire/ -- Summary Provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global ...
Researchers are exploring innovative immune-enhancing treatments known as host-directed therapies, aiming to harness the body's immune system to combat tuberculosis, including drug-resistant strains. ( ) The reported global number of ...
In a recent study tracking household contacts (individuals residing in the same dwelling) of tuberculosis (TB) patients, researchers discovered that undernourished contacts were three times more likely to develop TB disease. Interestingly, the study ...
Recent findings presented at the ESCMID Global Congress in Barcelona reveal that in a survey conducted by the VACCELERATE Consortium, infectious diseases experts ranked pathogens based on pandemic potential. The study identified influenza as the ...
Whooping cough, also known as pertussis , has emerged as a concerning health issue in China, with reports indicating 13 deaths within a span of just two months. This resurgence of the bacterial infection has sparked widespread ...
New research being presented at this year’s ESCMID Global Congress in Barcelona, Spain (27-30 April) suggests that tuberculosis (TB) can have long-term effects on the lungs of individuals who have been successfully treated for the ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers